menu search

Haemonetics (hae) q2 earnings top estimates, 2024 view up

The robust volume growth and price benefits in the plasma business driven by strong momentum in U.S. co...

November 3, 2023, 12:02 pm

General atomics congratulates jt60-sa research team on achieving first plasma

World’s largest operational superconducting tokamak achieved milestone on Oct. 23, 2023 San Diego, CA, Oct. 31, 2023 (GLOBE NEWSWIRE) — General At...

October 31, 2023, 4:20 pm

Pyrogenesis canada to voluntarily delist shares from nasdaq

PyroGenesis Canada Inc announced that it intends to voluntarily delist its common shares from the Nasdaq.  The provider of advanced ...

October 27, 2023, 9:31 am

Pyrogenesis wins c$360,000 contract for plasma-based system for chemical warfare waste destruction

PyroGenesis Canada Inc. (TSX:PYR, NASDAQ:PYR) announced it has secured an initial contract from a European engineering services firm working on the di...

October 24, 2023, 9:03 am

Kronos bio presents positive preliminary data from phase 1 dose escalation portion of phase 1/2 kb-0742 study at aacr-nci-eortc

Demonstrated on-mechanism, single agent anti-tumor activity in heavily pre-treated patients with transcriptionally addicted solid tumors Showed manage...

October 13, 2023, 4:30 pm

Fda approves pfizer's braftovi plus mektovi for a type of non-small cell lung cancer

Pfizer Inc. PFE, -0.18% said Thursday the U.S. Food and Drug Administration has approved its Braftovi plus Mektovi combination therapy as a treatment ...

October 12, 2023, 6:56 am

Relmada therapeutics to present new preclinical data on its psilocybin program at aasld the liver meeting® 2023

Low-dose psilocybin generated s tatistically significant reduc tions in liver fat content, plasma gluco...

October 11, 2023, 8:31 am

Athira pharma presents preclinical data further supporting the therapeutic potential of ath-1105 in amyotrophic lateral sclerosis (als)

New results support the neuroprotective effects of ATH-1105 in preclinical models of ALS, as indicated by consistent reduction in ...

October 5, 2023, 8:30 pm

Pyrogenesis canada provides positive update on purevap quartz reduction reactor and fumed silica projects

PyroGenesis Canada Inc provided an update on its strategic engineering partnership with HPQ on the PUREVAP Quartz Reduction Reaction (QRR) pilot pla...

October 3, 2023, 8:46 am

Pyrogenesis inks order with aerospace firm for 'coarse cut' titanium powder for 3d printing

PyroGenesis Canada Inc announced that it has received a small, signed order from a global aerospace firm pertaining to PyroGenesis' ...

September 19, 2023, 8:37 am

Pyrogenesis signs $2.25m plasma torch contract for pfas removal from water

PyroGenesis Canada Inc. (TSX:PYR, NASDAQ:PYR) told investors it has signed a contract valued at US$1.65 million with a US corporation to destroy perfl...

September 12, 2023, 8:16 am

Gain therapeutics presents new preclinical data demonstrating a reduction of plasma neurodegeneration biomarker nfl after administration of its drug candidate gt-02287 in gba1 parkinson’s disease mode

Treatment with GT-02287 also restored glucocerebrosidase (GCase) enzymatic function, reduced aggregated α-synuclein, neuroinflammation and neuronal d...

August 28, 2023, 11:00 am

Pyrogenesis canada receives $445k payment for sparc waste destruction system

PyroGenesis Canada Inc said it has received a milestone payment of $445,200 associated with the previously announced engineering phase for its SPARC r...

August 24, 2023, 8:34 am

Pyrogenesis canada receives $826k down payment for plasma torch system contract

PyroGenesis Canada Inc has confirmed the receipt of a $826,000 down payment associated with the previously-announced $4.1 million contract for a 4.5...

August 22, 2023, 8:33 am

Biotech firm csl's full-year profit rises on higher plasma collections

Australia's CSL reported an annual profit on Tuesday that rose 8% as higher plasma collections helped t...

August 14, 2023, 7:00 pm

Pfizer gets fda accelerated approval for multiple myeloma treatment

A Pfizer Inc. PFE, +0.52% treatment for relapsed or refractory multiple myeloma has received accelerated approval from the U.S. Food and Drug Administ...

August 14, 2023, 2:40 pm

Pyrogenesis achieves commercialization milestones during 2q

PyroGenesis has said that during the second quarter, it continued to expand into new markets as it reached commercialization goals for its ...

August 11, 2023, 8:59 am

Haemonetics (hae) q1 earnings top estimates, 2024 view up

The robust volume growth and price benefits in the plasma business drive Haemonetics' (HAE) fiscal firs...

August 9, 2023, 12:12 pm

Pyrogenesis schedules second quarter 2023 financial results and business update conference call

MONTREAL, Aug. 08, 2023 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech company ...

August 8, 2023, 5:40 pm

Pyrogenesis secures $4.1m contract for plasma torch system with us aeronautics client

PyroGenesis announced that it has won a $4.13 million contract for its 4.5 MW plasma torch system with ...

August 1, 2023, 8:22 am


Search within

Pages Search Results: